Wesley Research Institute
Donate
Now

This study is a world first collaboration between the St Andrew’s War Memorial Hospital, The University of Queensland and John Hopkins University to generate a digital pathology assessment of COVID-19 neural tissue using advanced imaging and genomics.

 

Research Objectives

Status

Completed

Recruitment

Closed

Study location

Wesley Research Institute, St Andrews Hospital and The University of Queensland

Study type

Investigator Initiated

Lead investigator

  • Associate Professor Arutha Kulasinghe

Experienced investigator

  • Professor John Fraser AO

About this research project

New research suggests that there may be long-term neurological consequences in those that survive severe COVID-19 infections, in particular brain damage that may lead to subtle cognitive, behavioural and cognitive problems.

The powerful technology will assess tissue for up to 100 proteins and 18,000 genes to provide an in-depth profile of cells that may be damaged and which neural pathways are activated or deactivated. This study into brain architecture and associated tissue pathologies will be key to gain insights into virally driven presentation of COVID-19 in the brain. It will form a world first dataset of the cellular and molecular changes to the brain in COVID-19 patients.

The data from this study will then be shared through publicly available platforms to enable the field of neuropathology and infectious diseases to interrogate the data. This will aid in understanding the changes to the brain post COVID-19 infection.

Latest News

Deep Dive: Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious, often misunderstood condition, characterised by abnormally high blood pressure in the arteries of the lung. Left untreated, it can lead to right heart failure and significantly reduce a person’s quality of life.

Clinical Trials Explained:  What to Expect and Why They’re Safer and More Valuable Than You Think

The idea of taking part in a clinical trial can feel a bit overwhelming. We're created this guide to help take the mystery out of clinical trials and show why they matter more than ever.

Living with FSHD: A Personal Journey of Strength, Hope, and Family

Meet Leona Luke: a 46-year-old mum from the Gold Coast. While her life seems like it’s all about family and fulfilling her everyday roles, Leona’s journey has been anything but typical. Leona was diagnosed with Facioscapulohumeral Muscular Dystrophy (FSHD), a progressive genetic disorder that weakens muscles over time.
1 2 3 25
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram